Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 673018, 7 pages
http://dx.doi.org/10.1155/2015/673018
Research Article

Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis?

1Department of Public Health and Clinical Medicine/Rheumatology, University of Umeå, 901 87 Umeå, Sweden
2Department of Surgical and Perioperative Sciences, University of Umeå, 901 87 Umeå, Sweden
3Department of Rheumatology, Östersund Hospital, 831 27 Östersund, Sweden
4Department of Rheumatology, Sunderby Hospital, 971 89 Luleå, Sweden

Received 7 March 2015; Accepted 23 April 2015

Academic Editor: Giuseppe Biondi-Zoccai

Copyright © 2015 Anna Södergren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Wållberg-Jonsson, H. Johansson, M.-L. Öhman, and S. Rantapää-Dahlqvist, “Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset,” Journal of Rheumatology, vol. 26, no. 12, pp. 2562–2571, 1999. View at Google Scholar · View at Scopus
  2. I. del Rincón, G. L. Freeman, R. W. Haas, D. H. O'Leary, and A. Escalante, “Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis,” Arthritis and Rheumatism, vol. 52, no. 11, pp. 3413–3423, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. P. H. Dessein, B. I. Joffe, M. G. Veller et al., “Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis,” Journal of Rheumatology, vol. 32, no. 3, pp. 435–442, 2005. View at Google Scholar · View at Scopus
  4. J. T. Giles, W. S. Post, R. S. Blumenthal et al., “Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis,” Arthritis & Rheumatism, vol. 63, no. 11, pp. 3216–3225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. K. Hansson, A. K. Robertson, and C. Soderberg-Naucler, “Inflammation and atherosclerosis,” Annual Review of Pathology, vol. 1, pp. 297–329, 2006. View at Google Scholar
  6. D. F. van Breukelen-van der Stoep, B. Klop, D. van Zeben, J. M. W. Hazes, and M. C. Cabezas, “Cardiovascular risk in rheumatoid arthritis: how to lower the risk?” Atherosclerosis, vol. 231, no. 1, pp. 163–172, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Molinari, G. Zeng, and J. S. Suri, “A state of the art review on intima-media thickness (IMT) measurement and wall segmentation techniques for carotid ultrasound,” Computer Methods and Programs in Biomedicine, vol. 100, no. 3, pp. 201–221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. D. H. O'Leary and M. L. Bots, “Imaging of atherosclerosis: carotid intima-media thickness,” European Heart Journal, vol. 31, no. 14, pp. 1682–1689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. W. Lorenz, H. S. Markus, M. L. Bots, M. Rosvall, and M. Sitzer, “Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis,” Circulation, vol. 115, no. 4, pp. 459–467, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. F. Polak, M. Szklo, R. A. Kronmal et al., “The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis,” Journal of the American Heart Association, vol. 2, no. 2, Article ID e000087, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Gonzalez-Juanatey, J. Llorca, J. Martin, and M. A. Gonzalez-Gay, “Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis,” Seminars in Arthritis & Rheumatism, vol. 38, no. 5, pp. 366–371, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. R. Evans, A. Escalante, D. F. Battafarano, G. L. Freeman, D. H. O'Leary, and I. del Rincõn, “Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 63, no. 5, pp. 1211–1220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Wållberg-Jonsson, C. Backman, O. Johnson et al., “Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis,” The Journal of Rheumatology, vol. 28, no. 12, pp. 2597–2602, 2001. View at Google Scholar · View at Scopus
  14. A. M. van Sijl, M. J. Peters, D. K. Knol et al., “Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis,” Seminars in Arthritis and Rheumatism, vol. 40, no. 5, pp. 389–397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Charakida, S. Masi, T. F. Lüscher, J. J. P. Kastelein, and J. E. Deanfield, “Assessment of atherosclerosis: the role of flow-mediated dilatation,” European Heart Journal, vol. 31, no. 23, pp. 2854–2861, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. D. J. Green, H. Jones, D. Thijssen, N. T. Cable, and G. Atkinson, “Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter?” Hypertension, vol. 57, no. 3, pp. 363–369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Shechter, A. Shechter, N. Koren-Morag, M. S. Feinberg, and L. Hiersch, “Usefulness of brachial artery flow-mediated dilation to predict long-term cardiovascular events in subjects without heart disease,” American Journal of Cardiology, vol. 113, no. 1, pp. 162–167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Thompson, P. Gao, L. Orfei et al., “Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies,” The Lancet, vol. 375, no. 9725, pp. 1536–1544, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Cai, D. Zheng, R. Qiu, W. Mai, and Y. Zhou, “Lipoprotein-associated phospholipase A2 (Lp-PLA-2): a novel and promising biomarker for cardiovascular risks assessment,” Disease Markers, vol. 34, no. 5, pp. 323–331, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. A. D. Tselepis, G. Hahalis, C. C. Tellis et al., “Plasma levels of lipoprotein-associated phospholipase A2 are increased in patients with β-thalassemia,” Journal of Lipid Research, vol. 51, no. 11, pp. 3331–3341, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. K. Garg, R. L. McClelland, N. S. Jenny et al., “Association of lipoprotein-associated phospholipase A2 and endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA),” Vascular Medicine, vol. 16, no. 4, pp. 247–252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Vittos, B. Toana, A. Vittos, and E. Moldoveanu, “Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker,” Biomarkers, vol. 17, no. 4, pp. 289–302, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. H.-P. Gong, Y.-M. Du, L.-N. Zhong et al., “Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis,” Lipids in Health and Disease, vol. 10, article 13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. R. Eckard, C. Longenecker, Y. Jiang et al., “Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection,” HIV Medicine, vol. 15, no. 9, pp. 537–546, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. D. N. Kiortsis, S. Tsouli, E. S. Lourida et al., “Lack of association between carotid intima-media thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia,” Angiology, vol. 56, no. 4, pp. 451–458, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Campo, M. A. Sardo, A. Bitto et al., “Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic sicilian individuals,” Clinical Chemistry, vol. 50, no. 11, pp. 2077–2082, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Liu, W. Wang, Y. Qi et al., “Association between the lipoprotein-associated phospholipase A2 activity and the progression of subclinical atherosclerosis,” Journal of Atherosclerosis and Thrombosis, vol. 21, pp. 532–542, 2014. View at Google Scholar
  28. A. Södergren, K. Karp, K. Boman et al., “Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness,” Arthritis Research & Therapy, vol. 12, no. 4, article R158, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Södergren, K. Karp, C. Bengtsson, B. Möller, S. Rantapää-Dahlqvist, and S. Wållberg-Jonsson, “The extent of subclinical atherosclerosis is partially predicted by the inflammatory load: a prospective study over 5 years in patients with rheumatoid arthritis and matched controls,” The Journal of Rheumatology, 2015. View at Publisher · View at Google Scholar
  30. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis & Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Publisher · View at Google Scholar · View at Scopus
  31. M. L. L. Prevoo, M. A. van 'T Hof, H. H. Kuper, M. A. van Leeuwen, L. B. A. van De Putte, and P. L. C. M. van Riel, “Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 38, no. 1, pp. 44–48, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Larsen, “How to apply larsen score in evaluating radiographs of rheumatoid arthritis in longterm studies?” Journal of Rheumatology, vol. 22, no. 10, pp. 1974–1975, 1995. View at Google Scholar · View at Scopus
  33. R. M. Conroy, K. Pyörälä, A. P. Fitzgerald et al., “Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project,” European Heart Journal, vol. 24, no. 11, pp. 987–1003, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. P. M. Ridker, J. E. Buring, N. Rifai, and N. R. Cook, “Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score,” Journal of the American Medical Association, vol. 297, no. 6, pp. 611–619, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Dulioust, P. Hilliquin, C.-J. Menkes, J. Benveniste, and B. Arnoux, “Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases,” Scandinavian Journal of Rheumatology, vol. 21, no. 4, pp. 161–164, 1992. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Hilliquin, A. Dulioust, C. Gregoir, A. Arnoux, and C. J. Menkes, “Production of PAF-acether by synovial fluid neutrophils in rheumatoid arthritis,” Inflammation Research, vol. 44, no. 8, pp. 313–316, 1995. View at Publisher · View at Google Scholar · View at Scopus
  37. G. L. Kinney, J. K. Snell-Bergeon, D. M. Maahs et al., “Lipoprotein-associated phospholipase A2 activity predicts progression of subclinical coronary atherosclerosis,” Diabetes Technology & Therapeutics, vol. 13, no. 3, pp. 381–387, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Saremi, T. E. Moritz, R. J. Anderson, C. Abraira, W. C. Duckworth, and P. D. Reaven, “Rates and determinants of coronary and abdominal aortic artery calcium progression in the Veterans Affairs Diabetes Trial (VADT),” Diabetes Care, vol. 33, no. 12, pp. 2642–2647, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. S. M. Boekholdt, B. J. Arsenault, S. Mora et al., “Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis,” The Journal of the American Medical Association, vol. 307, no. 12, pp. 1302–1309, 2012. View at Publisher · View at Google Scholar · View at Scopus